{"id":"W1528437986","doi":"10.1007/bf03256141","title":"Oral therapies for the treatment of pulmonary arterial hypertension","year":2009,"lang":"en","type":"article","venue":"Applied Health Economics and Health Policy","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"ca_institutions":"London Health Sciences Centre; Augmentium Pharma Consulting (Canada)","funders":"GlaxoSmithKline","keywords":"Medicine; Ambrisentan; Bosentan; Population; Intensive care medicine; Pharmacotherapy; Pharmacoeconomics; Pharmacy; Internal medicine; Adverse effect; Endothelin receptor antagonist; Endothelin receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001231291,0.0001804508,0.0006074003,0.0008351761,0.0003706088,0.00120457,0.000456553,0.00107693,0.01079777],"category_scores_gemma":[0.003495043,0.00007913238,0.0007295871,0.000629954,0.0007570407,0.0006801928,0.0006116031,0.002304248,0.0005116769],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008460714,"about_ca_system_score_gemma":0.001372834,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001266652,"about_ca_topic_score_gemma":0.003165556,"domain_scores_codex":[0.998893,0.0005208424,0.00007388322,0.000074126,0.0003705512,0.0000677219],"domain_scores_gemma":[0.9978632,0.001364733,0.0004100511,0.00007316679,0.0001421094,0.0001467206],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002968234,0.001193834,0.002645805,0.004369252,0.0004199609,0.0004690423,0.0001185164,0.001613989,0.003533988,0.1047352,0.02955079,0.8483813],"study_design_scores_gemma":[0.005851987,0.005657962,0.03263132,0.01337945,0.001575229,0.00288741,0.0008197341,0.003269887,0.006041205,0.1815,0.7462537,0.0001321069],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.03096097,0.8267577,0.006039891,0.05170557,0.003621632,0.0001433788,0.0005929888,0.00004404817,0.08013387],"genre_scores_gemma":[0.4612137,0.4880197,0.008825099,0.01110747,0.007678358,0.0003258325,0.0004536537,0.00002526602,0.02235092],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01079777,"threshold_uncertainty_score":0.03612214,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09898000564216994,"score_gpt":0.3872827167214887,"score_spread":0.2883027110793187,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}